MSH6 and MUTYH deficiency is a frequent event in early-onset colorectal cancer.

Clin Cancer Res

Gastroenterology Department, Institut de Malalties Digestives i Metabòliques, Hospital Clínic, Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Institut d'Investigacions Biomèdiques August Pi i Sunyer, (DIBAPS), University of Barcelona, Barcelona, Spain.

Published: November 2010

AI Article Synopsis

  • Early-onset colorectal cancer (CRC) is often linked to hereditary causes, particularly Lynch syndrome and the MUTYH gene, highlighting a need for deeper investigation in specific populations.
  • A study of 140 patients diagnosed with nonpolyposis CRC aged 50 or younger found that MMR (mismatch repair) deficiency is common, with 11.4% showing microsatellite instability, and 7.8% having germline MMR mutations, particularly in the MSH6 gene.
  • The results indicate that loss of MSH6 expression is a major factor in early-onset CRC, prompting recommendations for including MSH6 and MUTYH testing in genetic counseling for affected patients and their families.

Article Abstract

Purpose: Early-onset colorectal cancer (CRC) is suggestive of a hereditary predisposition. Lynch syndrome is the most frequent CRC hereditary cause. The MUTYH gene has also been related to hereditary CRC. A systematic characterization of these two diseases has not been reported previously in this population.

Experimental Design: We studied a retrospectively collected series of 140 patients ≤50 years old diagnosed with nonpolyposis CRC. Demographic, clinical, and familial features were obtained. Mismatch repair (MMR) deficiency was determined by microsatellite instability (MSI) analysis, and immunostaining for MLH1, MSH2, MSH6, and PMS2 proteins. Germline MMR mutations were evaluated in all MMR-deficient cases. Tumor samples with loss of MLH1 or MSH2 protein expression were analyzed for somatic methylation. Germline MUTYH mutations were evaluated in all cases. BRAF V600E and KRAS somatic mutational status was also determined.

Results: Fifteen tumors (11.4%) were MSI, and 20 (14.3%) showed loss of protein expression (7 for MLH1/PMS2, 2 for isolated MLH1, 3 for MSH2/MSH6, 7 for isolated MSH6, and 1 for MSH6/PMS2). We identified 11 (7.8%) germline MMR mutations, 4 in MLH1, 1 in MSH2, and 6 in MSH6. Methylation analysis revealed one case with somatic MLH1 methylation. Biallelic MUTYH mutations were detected in four (2.8%) cases. KRAS and BRAF V600E mutations were present in 39 (27.9%) and 5 (3.6%) cases, respectively.

Conclusions: Loss of MSH6 expression is the predominant cause of MMR deficiency in early-onset CRC. Our findings prompt the inclusion of MSH6 and MUTYH screening as part of the genetic counseling of these patients and their relatives.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032288PMC
http://dx.doi.org/10.1158/1078-0432.CCR-10-1491DOI Listing

Publication Analysis

Top Keywords

mlh1 msh2
12
msh6 mutyh
8
early-onset colorectal
8
colorectal cancer
8
mmr deficiency
8
msh2 msh6
8
germline mmr
8
mmr mutations
8
mutations evaluated
8
protein expression
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!